The overall pattern of released cytokines in the present study was similar; however, the anti-inflammatory cytokine IL-10 was also detectable in cycles 2 and 3, possibly because of the larger tumor load in patients with relapsed/refractory ALL, compared with MRD-positive ALL. Here, IL10 is linked to neoplasm.